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Abstract: 
 
A new indole alkaloid, namely malbrancheamide B (2), was isolated from the culture medium 
and mycelia of the ascomycete Malbranchea aurantiaca along with malbrancheamide (1). 
Structural elucidation of 2 was carried out by a combination of mass spectrometry (MS) and 1H 
and 13C NMR spectroscopy analyses, as well as by comparison of the NMR data with those of 1. 
According to the conformational studies using molecular mechanics analyses, compound 2 exists 
in one preferred conformation, which was optimised by density functional theory (DFT) 
calculations. Compound 2 is the second chlorinated indole alkaloid possessing a bicyclo [2.2.2] 
ring with an unusual relative configuration at C12a in the bicyclo [2.2.2] diazaoctane ring 
system. So far, these structural features seem to be unique for the alkaloids biosynthesised by the 
fungus M. aurantiaca. 
 
Keywords: Malbranchea aurantiaca | Malbrancheamide | Malbrancheamide B 
 
Article: 
 
1. Introduction 
 
Recently we reported the isolation and structural elucidation of malbrancheamide (1) (figure 1), 
an indole alkaloid possessing an unusual bicyclo [2.2.2] diazaoctane ring system1. This 
compound is related to the brevianamides, aspergamides, macfortines, paraherquamides, 
sclerotamides, and stephacidins2,3,4. These natural products have been isolated periodically from 
different strains of fungi of the genera Aspergillus and Penicillium since their discovery in 
19693–7. However, compound 1 was isolated from the culture of the ascomycete Malbranchea 
aurantiaca Singler and Carmich (Myxotrichaceae)1. Compound 1 is the first chlorinated indole 
alkaloid possessing the bicyclo [2.2.2] diazaoctane ring system. On the other hand, the relative 
configuration at C12a in the bicyclo [2.2.2] diazaoctane ring system is different to that of 
previous reported analogs. Altogether, these features make malbrancheamide (1) unique among 
these of complex indole alkaloid derivatives. Compound 1 caused moderate inhibition of radicle 
growth of seedlings of Amaranthus hypochondriacus and inhibited the activation of the 
calmodulin (CaM)-dependent enzyme PDE11. The latter effect was comparable to that of 
chlorpromazine, a well-characterised CaM antagonist. The inhibition mechanism of 1 was 
competitive with respect to CaM according to a kinetic analysis. 1-Hydroxy-2-oxoeremophil-
1(10), 7(11), 8(9)-trien-12(18)-olide and penicillic acid were also isolated from this species8. The 
present work was undertaken to isolate additional phytotoxic agents from M. 
aurantiaca resulting in the isolation of malbrancheamide B (2) (figure 1), a new chlorinated 
compound related to 1. 
 
 
Figure 1. Structures of alkaloids 1 and 2. 
 
2. Results and discussion 
 
Compound 2 (figure 1) gave a positive colour with Dragendorff's and Ehrlich's reagents and 
exhibited UV absorptions at 231 and 292 nm. Structure elucidation of 2 was carried out by a 
combination of mass spectrometry (MS) and 1H and 13C NMR spectroscopy analyses, as well as 
by comparison of the NMR data with those of 1. Thus, HREIMS gave a molecular ion 
[M]+ at m/z 369.1589 (Calcd for C21H24ON3Cl 369.1608), 35 uma less than compound 1. 
The 1HNMR spectrum of 2 (table 1) was almost identical to that of 1 except that the aromatic 
signals were observed as an ABX system [δH 7.31 (d, J = 8.7 Hz), 6.94 (dd, J = 1.8, 8.4 Hz) and 
7.26 (d, J = 1.7 Hz)] rather than the two singlets at δH 7.47 and 7.39 observed in the spectrum 
of 11. The 13C NMR spectrum (table 1) combined with the HSQC experiment revealed 21 carbon 
resonances and supported the presence of a lactam functionality and a mono-halogenated indole 
moiety. Altogether, this information suggested that 2 was a mono-chlorinated indole alkaloid 
similar to malbrancheamide (1). Detailed 2D-NMR spectral analyses (COSY, HETCOR, HMBC, 
and NOESY) led to the establishment of the connectivity of functional groups and, in turn, of the 
molecular structure. The position of the functional groups along the hexacyclic core was 
corroborated by an HMBC experiment (table 1). Thus, the correlations C-10a/H-7, C-6b/H-10, 
C-6a/H-6, H-7, C-5a/H-12a, C-12a/H-6, H-16, H-17, and C-11a/H-6, H-16, H-17 supported the 
position of the chlorine atom and the fusion of the indole nucleus to the dimethyl cyclohexane 
ring throughout C-6a and C-11a. On the other hand, the cross peaks C-5a/H-6, H-12a, H-13, H-5; 
C-12a/H-5 and C-13a/H-13, H-1, H-3, H-5 indicated that the bicyclo [2.2.2] diazaoctane ring 
system has the same arrangement that of 1. The location of the chorine atom at C-9 was 
corroborated by a NOESY experiment which showed the correlations H-10/H-11 and H-7/H-6A, 
H-6B. The relative stereochemistry at the chiral centers was elucidated as depicted on the basis 
of some key correlations observed in the NOESY spectrum which are summarised in figure 2. 
Biogenetic considerations as well as the Cotton effects observed in the CD spectrum of 2, almost 
indistinguishable to that of 1, tend to support that both compounds possess the same absolute 
configuration at the stereogenic centers. 
 
 
Figure 2. Optimized structure of compound 2 obtained by DFT analysis showing key NOESY 
correlations. 
 
Table 1. 13C and 1H NMR data of malbrancheamide B (2) 
No. δ13C δ1H (J Hz) HMBC 
 1 28.5 A 2.42 m H2, H3, H13 
    B 1.34 m   
 2 22.4 1.72 m H1, H3 
 3 55.2 A 2.93 ddd (9.6; 6.0, 2.1) H1, H2, H5 
    B 2.41 ddd (9.6; 6.0, 2.1)   
 5 59.5 A 2.13 d (9.9) H3, H6, H12a 
    B 3.25 d (9.9)   
5a 58.5 – H5, H6, H12a, H13, H16 
 6 29.9 A 2.79 d (15.9) H5, H12a 
    B 2.72 d (15.9)   
6a 103.7 – H6, H7 
6b 122.7 – H7, H8, H10 
 7 120.7 7.31 d (8.7) H8, H10 
 8 125.6 6.94 dd (1.8, 8.4) H7, H10 
 9 126.6 – H7, H8, H10 
10 112.1 7.26 d (1.7) H7, H8 
10a 135.4 – H7, H10 
11 – 11.04 s   
11a 144.4 – H6, H16, H17 
12 34.1 – H12a, H13, H16, H17 
No. δ13C δ1H (J Hz) HMBC 
12a 46.9 2.07 m H5, H6, H13, H16, H17 
13 33.9 A 1.98 m H1, H2 
    B 1.91 m   
13a 64.1 – H1, H3, H5, H12a, H13 
14 173.1 – H1, H13 
15 – 8.37 s   
16 31.1 1.26 s H12a, H17 
17 26.6 1.31 s H12a, H16 
 
As part of the structural characterisation, a conformational analysis of the new compound 2 using 
molecular modelling techniques was carried out. The initial structure was built from standard 
fragments and minimised using molecular mechanics analysis as implemented in the 
HyperChem® 7 program. A preliminary searching protocol using the Monte Carlo method9 was 
performed revealing a minimum energy conformer (E = 51.86 kcal mol−1); this conformer was 
fully optimized by density functional theory (DFT) at the B3LYP/G31G* level theory10. In the 
DFT optimised structure (E = −5200.84 kcal mol−1) ring F displays the same envelope 
conformation previously described for 1 with the atoms N4-C13a-C1-C2 located in the plane 
while C3 is out of the ring plane (figure 2). Due to the scarcity of the sample, the phytotoxic 
potential of 2 could not be established in the present investigation. 
 
In conclusion, malbrancheamide B (2) is the second chlorinated indole alkaloid possessing a 
bicyclo [2.2.2] ring with an unusual relative configuration at C12a in the bicyclo [2.2.2] 
diazaoctane ring system. So far, these structural features seem to be unique for the alkaloids 
biosynthesised by the fungus M. aurantiaca. 
 
3. Experimental section 
 
3.1. General experimental procedures 
 
The UV spectrum was recorded on a Shimadzu 160 UV spectrometer in MeOH solution. The CD 
spectrum was registered on a JASCO 720 spectropolarimeter at 25°C in MeOH solution. NMR 
spectra including COSY, NOESY, HMBC, and HSQC experiments were recorded in DMSO-
d 6 on a Varian spectrometer at 300 MHz (1H) or 75 MHz (13C) NMR, using tetramethylsilane 
(TMS) as internal standard. HREIMS was obtained on a JEOL JMS-AX505HA mass 
spectrometer. Column chromatography: silica gel 60 (70–230 mesh, Merck). TLC was 
performed on precoated silica gel 60 F254 plates (Merck). 
 
3.2. Fungal material 
 
The isolate of M. aurantiaca was obtained from bat guano collected at the Juxtlahuaca cave 
located in Ramal del Infierno, State of Guerrero, Mexico, in 1998. A voucher specimen (24428) 
is deposited in the National Herbarium (MEXU), Instituto de Biología, Universidad Nacional 
Autónoma de México, Mexico City. Three 2-L Erlenmeyer flasks, each containing 2 L of PDB 
(Difco), were individually inoculated with one 1-cm2 agar plug taken from a stock culture of M. 
aurantiaca maintained at 4°C on potato dextrose agar (PDA). Flask cultures were incubated at 
environmental temperature and aerated by agitation on an orbital shaker at 200 rpm for 15 days. 
 
3.3. Extraction and isolation 
 
After incubation, all flask contents were combined and filtered. The combined culture filtrate (6 
L) was extracted exhaustively with EtOAc (3 × 6 L). The combined organic phase was filtered 
over anhydrous Na2SO4 and concentrated in vacuo to give a dark brown solid (1.5 g). The 
mycelium was macerated with EtOAc (3 × 2 L). After evaporating the solvent in vacuo, the 
combined mycelial and culture extract (2.0 g) was subjected to silica gel (200 g) open column 
chromatography eluting with a gradient of CH2Cl2–EtOAc (10 : 0/0 : 10) and EtOAc : MeOH 
(10 : 0/0 : 10) to yield nine major primary fractions (FI-FIX). Bioactivity in the bioautographic 
bioassay showed one active pool: FIV (100 mg), eluted with EtOAc–MeOH (9 : 1). Fraction IV 
(100 mg) was submitted to prepare TLC on Silica gel eluted with EtOAc–MeOH (9 : 1); after 
usual work up 1 (15 mg) and 2 (3 mg) were obtained. 
 
3.4. Molecular modeling calculations 
 
Minimum energy structures were generated using the MMF94 (Monte Carlo Protocol) as 
implemented in the HyperChem 7 Program (Hypercube Inc., Gainesville, Florida). The 
conformational search was carried out by exploring torsional internal degrees of freedom of 
dihedral angles selected by the automatic set up procedure. The torsional angles considered were: 
C12a-C13-C13a, C13a-C1-C2, C1-C2-C-3, C2-C3-N4, N4-C5-C5a. The rotation angle was 30°. 
The minimum energy conformer was fully optimised by DFT at the B3LYP/G31G* level. 
 
Malbrancheamide B (2) 
 
Glassy solid. [α]D + 50° (c1, MeOH). IR (KBr) νmax: 3300, 1740, 1670, 1461, 1315, 1250 cm−1. 
UV λmax (MeOH) (log ε): 231 (3.95), 292 (4.80) nm: CD (MeOH) λmax (Δε): 244 (2 × 106), 217 
(1.3 × 106), 226 (1.2 × 106), 296 (1.5 × 105) nm; 1H and 13C NMR data, see table 1. 
EIMS m/z (rel. int.) 369 (7.5), 371 (2.00), 365 (6.5), 325 (100), 311 (27.1), 228 (39.1), 206 
(17.3), 163 (31.8), 164 (97.3), 163 (25), 135 (17.3), 120 (10), 96 (8.2); HREIMS: m/z 369.1589, 
calculated for C21H24ON3Cl: 369.1608. 
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